Brighton Marine, a non-profit organization dedicated to supporting military personnel and their families, has partnered with Freespira, Inc. to provide a groundbreaking digital therapeutic treatment for panic attacks, panic disorder, and post-traumatic stress disorder (PTSD). This collaboration marks a significant step in enhancing the healthcare options available to Brighton Marine Health Plan members, effective from November 2025.
Freespira is recognized as the first FDA-cleared solution designed specifically for these mental health conditions. By integrating this innovative treatment, Brighton Marine reaffirms its commitment to improving the physical and mental health of veterans through advanced healthcare solutions. The organization has a long history of serving military-connected families, administering the US Family Health Plan (USFHP) in Southern New England for over four decades.
“We’re excited to bring Freespira to our members who deserve access to a proven, virtual-first treatment for panic disorder and PTSD,” stated Dr. Rollinger of Brighton Marine. He emphasized that the treatment could lead to both short and long-term reductions in symptoms, empowering members to lead fuller lives.
The Freespira treatment addresses panic disorder and PTSD by targeting the physiological factors associated with these conditions. It works by normalizing breathing irregularities that develop due to carbon dioxide (CO2) hypersensitivity. Users receive real-time physiological feedback during their treatment sessions, which last 17 minutes and are conducted twice daily. This combination of a medical device and telehealth support ensures comprehensive guidance throughout the treatment process.
Joseph Perekupka, CEO of Freespira, highlighted the importance of offering new evidence-based options for individuals suffering from anxiety disorders. He remarked, “Freespira will enable Brighton Marine to address their members’ needs for improved access to care by offering a new, more convenient way to receive treatment for anxiety disorders that effectively engages members with a validated technology.”
Freespira, Inc. has established itself as a leader in digital therapeutic solutions, having developed the only FDA-cleared treatment that can significantly reduce or eliminate symptoms of panic disorder and PTSD within 28 days. Its medication-free approach not only aims to enhance the quality of life for users but also seeks to decrease healthcare costs and optimize the use of medical resources.
With this partnership, Brighton Marine and Freespira are poised to make a considerable impact on the mental health landscape for veterans and their families, facilitating access to innovative treatments that can potentially transform their lives.
